4.2 Article

Diagnostic value of I-123-ioflupane and I-123-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Meta-analysis of the literature on diagnostic accuracy of SPECT in Parkinsonian syndromes

Annemarie M. M. Vlaar et al.

BMC NEUROLOGY (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging

Vicky L. Marshall et al.

NUCLEAR MEDICINE COMMUNICATIONS (2006)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Article Clinical Neurology

Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases

M Plotkin et al.

JOURNAL OF NEURAL TRANSMISSION (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

GM Knudsen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)

Review Clinical Neurology

Functional brain imaging in the differential diagnosis of Parkinson's disease

P Piccini et al.

LANCET NEUROLOGY (2004)

Article Clinical Neurology

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

Z Walker et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases

C Prunier et al.

NUCLEAR MEDICINE COMMUNICATIONS (2001)

Article Clinical Neurology

The evolution of diagnosis in early Parkinson disease

J Jankovic et al.

ARCHIVES OF NEUROLOGY (2000)